CooperVision Names Gary Orsborn Vice President of Global Professional & Clinical Affairs

CooperVision Names Gary Orsborn Vice President of Global Professional & Clinical Affairs


PLEASANTON, Calif., January 20, 2015  CooperVision, Inc. has named Gary Orsborn, O.D., M.S., FAAO, FBCLA, Vice President, Global Professional & Clinical Affairs. In this role, he is responsible for the continued development and management of the company’s professional and clinical affairs strategy worldwide.

 

Dr. Orsborn has nearly 30 years of experience in the contact lens industry, working in the United States, Latin America, and Europe. His expertise spans a variety of areas, including: medical affairs; management of field clinical studies of marketed and developmental contact lenses and care products; development of practitioner educational materials; worldwide professional relations; and marketing of vision care products.  

 

“Gary’s expertise is not only a benefit to CooperVision, but he is a tremendous asset to the eye care industry as a whole,” said Jerry Warner, Senior Vice President, Global Marketing, CooperVision, Inc. “The combination of his experience, existing relationships, and insight enables Gary to help CooperVision identify and meet the needs of eye care practitioners around the world. As a company, we pride ourselves on our ability to be more than a contact lens manufacturer for our customers—we are a trusted partner. Gary is well known and respected for his work within the industry, and I know that he will serve us well in this role.”

 

Dr. Orsborn previously served as Senior Director, Global Professional Affairs, a position he held since joining CooperVision in 2013. In that role, he led CooperVision’s North America Professional & Academic Affairs team. Prior to that, Dr. Orsborn was with Bausch + Lomb for 28 years. During that time, he served in various positions, including Director of Medical Affairs Pharmaceuticals and Vision Care and Director of Contact Lens and Professional Marketing for Europe, the Middle East, and Africa.

 

Dr. Orsborn received his Doctor of Optometry degree and a Master of Science in physiological optics from The Ohio State University College of Optometry. He is a fellow of both the American Academy of Optometry and of the British Contact Lens Association, and a member of the American Optometric Association and the Association of Research and Vision in Ophthalmology.

 

Dr. Orsborn is based at CooperVision’s offices in Fairport, N.Y.

 

About CooperVision


CooperVision, a unit of The Cooper Companies, Inc. (NYSE:COO), is one of the world’s leading manufacturers of soft contact lenses and related products and services. The Company produces a full array of monthly, two-week and daily disposable contact lenses, all featuring advanced materials and optics. CooperVision has a strong heritage of solving the toughest vision challenges such as astigmatism and presbyopia; and offers the most complete collection of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers. For more information, visitwww.coopervision.com.

 

About The Cooper Companies

The Cooper Companies, Inc. ("Cooper") is a global medical device company publicly traded on the NYSE Euronext (NYSE:COO). Cooper is dedicated to being A Quality of Life Company™ with a focus on delivering shareholder value. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to crafting a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical focuses on supplying women's health clinicians with market-leading products and treatment options to improve the delivery of healthcare to women. Headquartered in Pleasanton, Calif., Cooper has approximately 9,000 employees with products sold in over 100 countries. For more information, please visit www.coopercos.com.